Hexamethylmelamine for the treatment of ovarian cancer--the Mount Sinai experience.

[1]  E. Feuer,et al.  Schedule and dosage modification of a cyclophosphamide, hexamethylmelamine, doxorubicin, cisplatin combination chemotherapy regimen for refractory ovarian cancer. , 1989, European journal of cancer & clinical oncology.

[2]  E. Feuer,et al.  Modulation and intensification of a cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin ovarian cancer regimen , 1989, Obstetrics and gynecology.

[3]  J. Edmonson,et al.  Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack? , 1988, Journal of the National Cancer Institute.

[4]  J. Hainsworth,et al.  Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration. , 1988, Annals of internal medicine.

[5]  J. Neijt,et al.  Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Bruckner Hw.  Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack?". , 1987 .

[7]  Hryniuk Wm.  Average relative dose intensity and the impact on design of clinical trials. , 1987, Seminars in oncology.

[8]  E. Feuer,et al.  Prognostic factors: Cisplatin regimens for patients with ovarian cancer after failure of chemotherapy , 1987, Obstetrics and gynecology.

[9]  J. Neijt,et al.  RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMA , 1984, The Lancet.

[10]  C. Cohen,et al.  Cisplatin regimens and improved prognosis of patients with poorly differentiated ovarian cancer. , 1983, American journal of obstetrics and gynecology.

[11]  C. Cohen,et al.  Treatment of chemotherapy-resistant advanced ovarian cancer with a combination of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-diamminedichloroplatinum (CHAP). , 1981, Gynecologic oncology.

[12]  C. Cohen,et al.  High-dose platinum for the treatment of refractory ovarian cancer. , 1981, Gynecologic oncology.

[13]  C. Cohen,et al.  Improved chemotherapy for ovarian cancer with cis‐diamminedichloroplatinum and adriamycin , 1981, Cancer.

[14]  C. Cohen,et al.  Chemotherapy of Recurrent Ovarian Carcinoma with cis‐Dichlorodiammine Platinum II and Adriamycin , 1980, Obstetrics and gynecology.

[15]  R. Ozols,et al.  Histologic grade in advanced ovarian cancer. , 1979, Cancer treatment reports.

[16]  C. Cohen,et al.  Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy. , 1978, Cancer treatment reports.

[17]  C. Cohen,et al.  Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapy. , 1978, Cancer treatment reports.

[18]  Griffiths Ct.  Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. , 1975 .

[19]  C. Wilson,et al.  FENFLURAMINE AND DREAMING , 1974 .

[20]  C. Cohen,et al.  Ovarian cancer: schedule modification and dosage intensification of cyclophosphamide, hexamethylmelamine, adriamycin and Cis-platin regimen (CHAP II) , 1982 .

[21]  J. Wharton,et al.  Long Term Survival Following Chemotherapy for Advanced Epithelial Ovarian Carcinoma , 1980 .

[22]  H. Bruckner,et al.  Chemotherapy of gynecological tumors with platinum II , 1977 .